ask="N/A"
ask_size="N/A"
average_daily_volume="7233"
bid="N/A"
bid_size="N/A"
book_value="2.6090"
change="-0.0541"
change_from_200_day_moving_average="-0.8747"
change_from_50_day_moving_average="-0.6121"
change_from_52_week_high="-2.1541"
change_From_52_week_low="0.9358"
change_in_percent="-1.5028%"
close="3.5459"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.7700"
ebitda="-19.70M"
eps_estimate_current_year="-1.6500"
eps_estimate_next_quarter="-0.4400"
eps_estimate_next_year="-1.7000"
ex_dividend_date="N/A"
float_shares="1878000"
high="3.7400"
high_52_weeks="5.7000"
last_trade_date="1/12/2017"
last_trade_price="3.5459"
last_trade_size="200"
last_trade_time="1:31pm"
low="3.5459"
low_52_weeks="2.6101"
market_capitalization="41.58M"
moving_average_200_day="4.4206"
moving_average_50_day="4.1580"
name="Nexvet Biopharma plc - Ordinary"
notes="N/A"
one_year_target_price="8.0000"
open="3.6800"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-19.7869%"
percent_change_from_50_day_moving_average="-14.7204%"
percent_change_from_52_week_high="-37.7912%"
percent_change_from_52_week_low="+35.8530%"
previous_close="3.6000"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.3798"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="11726000"
short_ratio="11.2400"
stock_exchange="NGM"
symbol="NVET"
volume="2421"
weeks_range_52="2.6101 - 5.7000"
